Family Nurture Intervention in the NICU at The Valley Hospital

Sponsor
Columbia University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03267043
Collaborator
(none)
150
2
4
49.4
75
1.5

Study Details

Study Description

Brief Summary

The purpose of this study is to compare neurodevelopment and activity in infants born preterm (25 to 34 1/7 weeks gestational age (GA)) receiving Standard Care (SC) or Family Nurture Intervention (FNI) in the neonatal intensive care unit (NICU).

The investigators hypothesize that FNI will improve: i) neonatal electroencephalographic activity ii) maternal caregiving and wellbeing (psychological and physiological, and iii) infant behavior and neurodevelopment at 18 months corrected age (CA).

The two-phase effectiveness study aims to:
  • Phase 1 - Examine the existing Standard Care Approximately 35 infants and their mothers

  • Phase 2 - Examine effectiveness by implementing FNI unit-wide so that every baby receives the intervention Approximately 35 infants and their mothers

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Family Nurture Intervention (FNI)
  • Behavioral: Standard Care
N/A

Detailed Description

This study aims to build upon the findings of the earlier randomized controlled trial (RCT) conducted at the Columbia University Medical Center (CUMC) comparing effects, both physiological and emotional, of the current standard method of encouraging contact between mothers and their babies in the NICU with the more specific approach of Family Nurture Intervention (FNI). In addition to receiving standard care, NICU families assigned to FNI received added intervention that focused on supporting the parents and facilitating emotional connection between mother and infant during the infant's NICU stay.

The investigators wish to conduct an effectiveness trial to evaluate if the family nurture intervention's findings can be replicated on a unit-wide level. This effectiveness trial will take place over two parts. There will be two groups; standard care (SC) and intervention (FNI). Phase 1 of the effectiveness study will evaluate the standard care (SC) group in the unit as a baseline measurement and point of comparison to determine if unit-wide FNI reproduces its prior findings (Phase 2). The standard care group (Phase 1) will receive the current standard of care in the NICU. In Phase 2, FNI will be implemented unit-wide, but infants born between 26 weeks and 0 days to 33 weeks 6 days gestation will be eligible to be enrolled into the study. In addition to receiving standard care, patients enrolled during phase 2 will receive added interventions from the trained FNI nursing staff. These added interventions will include supporting the parents and facilitating contact between mother and infant during their infant's NICU stay.

Study Design

Study Type:
Interventional
Actual Enrollment :
150 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Family Nurture Intervention in the NICU at The Valley Hospital
Actual Study Start Date :
Oct 20, 2017
Actual Primary Completion Date :
Mar 19, 2020
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard Care

Participants enrolled in Phase 1 will be receiving the current standard of care in the NICU at The Valley Hospital.

Behavioral: Standard Care
Established routine care provided on the NICU floor by specially trained health care professionals.
Other Names:
  • SC
  • Experimental: Family Nurture Intervention (FNI)

    Participants enrolled in Phase 2 will be receiving family nurture intervention (FNI) that focuses on supporting the parents and facilitating emotional connection between mother and infant during the infant's NICU stay.

    Behavioral: Family Nurture Intervention (FNI)
    Subjects will be guided by the nursing staff through an enhanced program of mother/infant interactions, which include skin-to-skin holding.
    Other Names:
  • FNI
  • Active Comparator: Standard Care - Case Studies

    Participants enrolled as case studies in Phase 1 will be receiving the current standard of care in the NICU at The Valley Hospital. These participants will be those who fall outside the inclusion criteria.

    Behavioral: Standard Care
    Established routine care provided on the NICU floor by specially trained health care professionals.
    Other Names:
  • SC
  • Experimental: FNI - Case Studies

    Participants enrolled in Phase 2 will be receiving family nurture intervention (FNI) that focuses on supporting the parents and facilitating emotional connection between mother and infant during the infant's NICU stay. These fall outside the inclusion criteria but act as a comparator to the case studies of Phase 1.

    Behavioral: Family Nurture Intervention (FNI)
    Subjects will be guided by the nursing staff through an enhanced program of mother/infant interactions, which include skin-to-skin holding.
    Other Names:
  • FNI
  • Outcome Measures

    Primary Outcome Measures

    1. EEG Power in the frontal polar region [Up to 41 weeks gestational age]

      Measured in microvolts (µV)^2 for infants.

    Secondary Outcome Measures

    1. EEG Coherence in the left frontal polar to right frontal polar region [Up to 41 weeks gestational age]

      Coherence is a number between 0-1, generated by looking at the similarity/differences in activity between brain regions through analysis of EEG.

    2. CES-D Score [Up to 18 months]

      To examine maternal depression, the Center for Epidemiologic Studies Depression Scale (CES-D) is a 20 item self-report inventory designed to assess current but nonspecific distress rather than clinically diagnosed depression. It is the most frequently used measure in the field of infant research and maternal depression. Items probe for depressive symptoms and attitudes within the past week.

    3. State-Trait Anxiety Inventory (STAI) Score [Up to 18 months]

      To examine Maternal Anxiety, the State-Trait Anxiety Inventory (STAI) comprises 2 separate self-report scales of 20 items each that measure state and trait anxiety. The S-Anxiety Scale (measuring state), has been found to be a sensitive indicator of changes in transitory anxiety experienced by patients in counseling, psychotherapy, and behavior-modification programs, and has been used to assess the level of anxiety induced by unavoidable real-life stressors. The T-Anxiety scale has proven useful for identifying persons who differ in motivation or drive level. The STAI has been used in studies examining parents of hospitalized children, the transition to a maternal role, perception of illness severity in infants, and maternal anxiety during pregnancy and fetal attachment.

    4. Neurobehavioral Assessments of Infants - Bayley Scales or Infant and Toddler Development, Bayley III [Up to 18 months]

      At the 18 month corrected age follow-up, infants are administered the Bayley Scales of Infant and Toddler Development, Bayley III consisting of three developmental domains: Cognitive, Language (receptive/expressive) and Motor (fine/gross). For each domain, a composite score is provided and is scaled to a mean score of 100 and a standard deviation of 15. A child will receive 1 point for every item successfully completed. The administration of each section will end if the child received 0 points on 5 consecutive items. Scores <70 indicate significant developmental delays and scores <80 indicate mild to moderate developmental delays. Cognitive Scale - comprised of 91 items Language Scale - comprised of 97 items Motor Scale - comprised of 138 items

    Other Outcome Measures

    1. Welch Emotional Connection Scale [Up to 18 months]

      To examine Mother-Infant Emotional Connection, this is a brief 4-item assessment requiring 5 minutes or less, which assesses the character of the relationship between study mothers and infants. It is filled out by study staff who rate mothers and infants in a dyadic interaction on their attraction, their vocal communication, facial expressiveness, and sensitivity and responsivity towards each other.

    2. Child Behavior Checklist Score [Up to 18 months]

      The Child Behavior Checklist (CBCL) is a device by which parents rate their child's problem behaviors and competencies. The CBCL can also be used to measure a child's change in behavior over time or following a treatment. The CBCL consists of 100 items. This will be administered at the 18 Months CA Follow-Up.

    3. Modified Checklist for Autism in Toddlers (M-CHAT) Score [Up to 18 months]

      The M-CHAT is a questionnaire validated for screening toddlers to assess risk for autism spectrum disorders (ASD). It is a 23 yes/no item questionnaire administered to the mother which can be scored in less than 2 minutes. This will be administered at the 18 Month CA Follow-Up.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    26 Weeks to 34 Weeks
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    For the Standard Care and FNI Groups

    Inclusion Criteria:
    • infant is between 26 and 33 6/7 weeks gestational age upon admission

    • infant is a singleton or twin

    Exclusion Criteria:
    • infant's attending physician does not recommend enrollment in the study

    • severe congenital anomalies including chromosomal anomalies

    • ultrasound evidence of large parenchymal hemorrhagic infarction (>2 cm, intraventricular hemorrhage grade 3 or 4)

    • infant cardiac anomalies

    • mother has known history of substance abuse, severe psychiatric illness or psychosis

    • status of enrolled subject changes and subject now falls into exclusion criteria

    • mother and/or infant has a medical condition that precludes intervention components

    • mother and/or infant has a contagion that endangers other participants in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Valley Hospital Ridgewood New Jersey United States 07450
    2 Morgan Stanley Children's Hospital of New York (MSCHONY) New York New York United States 10032

    Sponsors and Collaborators

    • Columbia University

    Investigators

    • Principal Investigator: Martha G Welch, MD, Columbia University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Martha G Welch, Associate Professor of Psychiatry (in Pediatrics and Pathology and Cell Biology), Columbia University
    ClinicalTrials.gov Identifier:
    NCT03267043
    Other Study ID Numbers:
    • AAAR4899
    First Posted:
    Aug 30, 2017
    Last Update Posted:
    Apr 19, 2021
    Last Verified:
    Apr 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Martha G Welch, Associate Professor of Psychiatry (in Pediatrics and Pathology and Cell Biology), Columbia University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 19, 2021